Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 18, 2020 / 07:00PM GMT
Release Date Price: €179 (+7.19%)
Benjamin Whitman Mayo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare Facilities and Managed Care

Great. Let's go ahead and get started. Sorry for the delay. We were having a little dial-in issue on our end. But it's my pleasure to have the team from Amedisys. Not exactly sure who all is on the line. I think, Paul, Nick, maybe Chris. So I don't know who -- you want to give a quick introduction, Paul?

Paul Berthold Kusserow
Amedisys, Inc. - Chairman, President & CEO

Yes. Whit, Paul Kusserow here, CEO. We've got Chris Gerard, COO; Scott Ginn, CFO; and Nick Muscato. That's everything...

Benjamin Whitman Mayo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare Facilities and Managed Care

Whole team.

Paul Berthold Kusserow
Amedisys, Inc. - Chairman, President & CEO

Yes.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot